Pioneering a new standard of care in regenerative medicine and drug delivery


Viamer Biosciences is driven by a commitment to deliver biomedical solutions that improve patients’ lives.

Our dedicated team has vast experience in polymer chemistry and drug delivery. We are focused on creating advanced biomaterial technologies to tackle critical, unmet needs in public health, including solutions for non-opioid pain management, infection control, and regenerative medicine.

We are ushering in a new era of bioresorbable therapies designed to prioritize optimal patient outcomes.


Our revolutionary biomaterial platform, CYPREXis based on our patented poly(ester urea) technology. These versatile polymers enable customizable chemistry with the ability to fine-tune physical properties, resorption rate, and drug delivery. Our CYPREX materials are highly biocompatible and have demonstrated controlled drug release in the form of films, fibers, scaffolds, and adhesives. 


We are actively partnering with biotech companies to co-develop the next-generation of resorbable implantable therapeutics.


Contact us to learn more.


Gray Pub Molecules-01

Controlled Release of Etoricoxib from Poly(ester urea) Films for Post-operative Pain Management

“Implementation of local drug delivery systems such as this could reduce the need for opioid prescriptions associated with current pain management strategies.”

Antibiotic Eluting Poly(ester urea) Films for Control of a Model Cardiac Implantable Electronic Device Infection

“Antibiotic loaded PEU films function as an effective sustained release matrix for localized delivery of antibiotics across a number of clinical indications.”

Phenylalanine-Based Poly(ester urea): Synthesis, Characterization, and In Vitro Degradation

“[PEUs] have proven to be important materials for biomedical applications because of their excellent blood, tissue compatibility, and nontoxic hydrolysis byproducts.”

“We demonstrate that peptides immobilized on the surface of 3D printed PEU scaffolds promote hMSCs osteogenic differentiation by measuring the expression of osteogenic phenotype markers and enhanced mineralization.”

“The adhesive strengths of [PEU] copolymers on bone samples were significant…and comparable to commercially available poly(methyl methacrylate) bone cement.”

“The mechanical properties of these PEU copolymers demonstrate improved mechanical properties when used concomitantly with SIS-ECM as composite materials or as free-standing films thus improving on the state of the art material currently employed for hernia repair.”


If you’re interested in our technology, open positions or investment opportunities, please contact us.

2202 Ellis Rd. Durham, NC 27703

© 2022 Viamer Biosciences